Request a Quote
Part detail

RFQ For 07924-03 NSN part by Hospira Inc with NSN 6505013724486

07924-03NSN6505-01-372-4486CAGE3VBU6

Dextrose And Sodium

Detailed description

07924-03 procurement notes

Thank you for having an interest in part number 07924-03, an item from Hospira Inc (CAGE Code 10001) that is listed with the description - Support. Be sure to review the details provided on this page, and should you wish to move forward with procurement, fill out and submit the Request for Quote (RFQ) form provided below at your earliest convenience.

If you also require other items from FSC or wish to speak with staff directly, do not hesitate to give us a call or email at any time. We are ready to support you with competitive options for part number 07924-03and other items of interest, so be sure to get in touch today!

Specifications

Reference data

Manufacturer
Hospira Inc
Part number
07924-03
NSN
6505-01-372-4486
NIIN
01-372-4486
FSC
6505 Drugs and Biologicals
CAGE code
3VBU6
INC code
10144
Country
USA
Part type
Dextrose And Sodium
Sub part type
—
Specification
—
Multi-line procurement

Sourcing more than one part?

Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.

Compliance
  • AS9120:2025· Aerospace QMS
  • ISO 9001:2015· Quality Management
  • FAA AC 00-56B· Voluntary Industry Distributor Accreditation
  • U.S. ONLY· Fulfillment

Characteristics Data of NSN 6505-01-372-4486, 6505013724486

MRCCriteriaCharacteristic
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
CQCTPRIMARY CONTAINER TYPEBAG WITH HANGING DEVICE, PLASTIC
CRLKPRIMARY CONTAINER CONTENT QUANTITY500.000 MILLILITERS
CSCWTOTAL PRIMARY CONTAINER QUANTITY24
CXCYIII PART NAME ASSIGNED BY CONTROLLING AGENCYDEXTROSE AND SODIUM CHLORIDE INJECTION USP 500ML PLASTIC BAG 24S
FEATSPECIAL FEATURESW/OVERPOUCH AS WATER VAPOR BARRIER. EXPOSURE OF PHARMACEUTICAL PRODUCTS TO HEAT SHOULD BE MINIMIZED. AVOID EXCESSIVE HEAT. IT IS RECOMMENDED THE PRODUCT BE STORED AT ROOM TEMPERATURE (25 C); BRIEF EXPOSURE UP TO 40 C DOES NOT ADVERSELY AFFE
MDESMEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA